Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/384330
Full metadata record
DC FieldValueLanguage
dc.coverage.spatial
dc.date.accessioned2022-06-06T09:44:46Z-
dc.date.available2022-06-06T09:44:46Z-
dc.identifier.urihttp://hdl.handle.net/10603/384330-
dc.description.abstractAIDS is a life threatening condition caused by Human Immunodeficiency Virus (HIV). AIDS is responsible for supressing immunity which spreads and transmits through blood and sex. According to WHO, around 41,758,381 people have already suffered from AIDS since 1986 with African and Asian countries have maximum number of HIV patients. A total number of 566,113 people had died due to AIDS and related illness at the end 0f 2019. HIV is a retrovirus which consist 3 integral enzymes responsible for its survival including reverse transcriptase, protease and integrase. Many drugs have approved in last 3 decades inhibiting these enzymes but most of drugs have problems of Drug resistance, side effects, toxicities and poor bioavailability. In course of our research to design and discover potent and bioactive anti-HIV agents, we have used ligand and structure based drug design approaches. A total number of 4 pharmacophore hypotheses were generated (3 Ligand based and 1 structure based). The common features obtained in pharmacophore were hydrogen bond donor, hydrogen bond acceptor and hydrophobic region. All these 4 models were validated and were used to search substructure from different databases. 3D-QSAR (CoMFA and CoMSIA) model was generated using 3 different alignment techniques including multifit alignment, docking based and distill based alignment for 63 compounds. A distill based alignment method was considered as better method according to different validation parameters and contour maps generated from CoMFA and CoMSIA models. A triazine ring was designed by incorporating pharmacophoric features and contour maps. The designed molecules were docked on HIV-I protease enzyme to predict binding affinities. In silico Pharmacokinetic and toxicities were also predicted using QikProp and OSIRIS. A total number of 32 compounds were synthesized and were characterized using FTIR, mass, 1H NMR and 13C NMR. The purity of all synthesized compounds were checked using HPLC. All synthesised compounds were evaluated fo
dc.format.extent
dc.languageEnglish
dc.relation
dc.rightsuniversity
dc.titleDesign Synthesis and Biological Evaluation of Triazine Derivatives as Anti HIV Agents
dc.title.alternative
dc.creator.researcherPatel Paresh
dc.subject.keywordAIDS
dc.subject.keywordImmunodeficiency
dc.subject.keywordNMR
dc.description.note
dc.contributor.guideBhatt Hardik
dc.publisher.placeAhmedabad
dc.publisher.universityNirma University
dc.publisher.institutionInstitute of Pharmacy
dc.date.registered2014
dc.date.completed2021
dc.date.awarded2021
dc.format.dimensions
dc.format.accompanyingmaterialDVD
dc.source.universityUniversity
dc.type.degreePh.D.
Appears in Departments:Institute of Pharmacy

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File105.14 kBAdobe PDFView/Open
02_certificate.pdf292.87 kBAdobe PDFView/Open
03_abstract.pdf181.72 kBAdobe PDFView/Open
04_declaration.pdf306.86 kBAdobe PDFView/Open
05_acknowledgement.pdf112.34 kBAdobe PDFView/Open
06_contents.pdf305.49 kBAdobe PDFView/Open
07_list of tables.pdf191.79 kBAdobe PDFView/Open
08_list of figures.pdf193.29 kBAdobe PDFView/Open
09_list of abbreviations.pdf184.9 kBAdobe PDFView/Open
10_chapter_1.pdf481.2 kBAdobe PDFView/Open
11_chapter_2.pdf940.26 kBAdobe PDFView/Open
12_chapter_3.pdf292.97 kBAdobe PDFView/Open
13_chapter_4.pdf693.45 kBAdobe PDFView/Open
14_chapter_5.pdf779.68 kBAdobe PDFView/Open
15_chapter_6.pdf708.02 kBAdobe PDFView/Open
16_chapter_7.pdf1.08 MBAdobe PDFView/Open
17_chapter_8.pdf319.76 kBAdobe PDFView/Open
18_chapter_9.pdf188.2 kBAdobe PDFView/Open
80_recommendation.pdf287.72 kBAdobe PDFView/Open


Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: